DavidSchneiderMD
Cardiology • Burlington, VTAdult Congenital Heart Disease, Echocardiography
Physician
Dr. Schneider is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 Colchester Ave
Cardiology Division
Burlington, VT 05401Phone+1 802-547-2879Fax+1 802-847-2533
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Cardiovascular Disease, 1990 - 1994
University of ColoradoResidency, Internal Medicine, 1986 - 1990
University of Cincinnati College of MedicineClass of 1986
Certifications & Licensure
NY State Medical License 1999 - 2026
VT State Medical License 1994 - 2026
CO State Medical License 1987 - 1991- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Cangrelor Ticagrelor Transition Study Start of enrollment: 2013 Jan 01
- Cangrelor Prasugrel Transition Study Start of enrollment: 2013 Jun 01
- Cangrelor to Clopidogrel or Prasugrel Transition Study Start of enrollment: 2013 Dec 02
- Join now to see all
Publications & Presentations
PubMed
- 26 citationsPlatelet phenotype changes associated with breast cancer and its treatmentChris E. Holmes, Jamie E. Levis, David J. Schneider, Nadia M. Bambace, Deva Sharma
Platelets. 2016-05-02 - 30 citationsAssociation Between Increased Platelet P-Selectin Expression and Obesity in Patients With Type 2 Diabetes: A BARI 2D (Bypass Angioplasty Revascularization Investigatio...David J. Schneider, Regina M. Hardison, Neuza Lopes, Burton E. Sobel, Maria M. Brooks
Diabetes Care. 2009-05-01 - 116 citationsStimulation by Proinsulin of Expression of Plasminogen Activator Inhibitor Type-I in Endothelial CellsDavid J. Schneider, Thomas K Nordt, Burton E. Sobel
Diabetes. 1992-07-01
Press Mentions
FcγRIIa: A Marker of Cardiovascular Risk After Myocardial InfarctionOctober 21st, 2024
What’s the Point of Plants That Make Us Feel High?March 5th, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
